Second Phase 3 study results for LMTX published

Second Phase 3 study results for LMTX published:

Dementia Big
TauRx Therapeutics Ltd today reported the full results from its second Phase 3 clinical study of LMTX, the first tau aggregation inhibitor in Alzheimer’s disease, published online in the Journal of Alzheimer’s Disease.

http://ift.tt/2i1SkwA